Kathryn J. Ruddy, MD, MPH
Kathryn J. Ruddy, MD, MPH, is a board certified medical oncologist and director of cancer survivorship for medical oncology at the Mayo Clinic in Rochester, MN. She was a breast oncologist at Dana-Farber Cancer Institute in Boston, Mass., for 4 years.
Dr. Ruddy is board certified in hematology, medical oncology and internal medicine, and her current areas of interest include cancer survivorship, premenopausal breast cancer, fertility, and male breast cancer. She is a medical reviewer for Living Beyond Breast Cancer and contributed to our Guide to Understanding Triple-Negative Breast Cancer.
- Chemotherapy Before Surgery May Be Most Beneficial in Very Young Women
- Guide to Understanding Triple-Negative Breast Cancer
- Communicating With Doctors and Other Providers
- More Pre-Surgery Trastuzumab Not More Effective
- Metastatic Breast Cancer: Emerging Research
- Breast Cancer Response to Pre-Surgery Chemotherapy May Suggest its Benefit in Long-term